15.03.2015 Views

April 2012 Drug Information Update - Pharmacy Benefits ...

April 2012 Drug Information Update - Pharmacy Benefits ...

April 2012 Drug Information Update - Pharmacy Benefits ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Daunorubicin Hydrochloride Injection<br />

March 20, <strong>2012</strong><br />

Products Affected - Description<br />

Daunorubicin hydrochloride solution for injection, 5 mg/mL, Bedford<br />

4 mL single-dose vial (NDC 55390-0108-10)<br />

4 mL single-dose vial, Novaplus (NDC 55390-0142-10)<br />

10 mL single-dose vial (NDC 55390-0108-01)<br />

Daunorubicin hydrochloride lyophilized powder for injection, Bedford<br />

20 mg single-dose vial, package of 10, Novaplus (NDC 55390-0805-10)<br />

Cerubidine lyophilized powder for injection, Bedford<br />

20 mg single-dose vial, package of 10 (NDC 55390-0281-10)<br />

Reason for the Shortage<br />

• Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011 on a<br />

temporary basis for maintenance and requalification of equipment. Product will become available<br />

in stages as production resumes.<br />

• Bedford Laboratories has multiple products affected by this suspension of manufacturing.<br />

Availability of all products, including those not manufactured at Ben Venue, is updated as<br />

information changes on the Bedford Laboratories website.<br />

• Teva had daunorubicin on shortage due to manufacturing issues.<br />

Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=680<br />

Source: www.ashp.org<br />

Dacarbazine Injection<br />

March 20, <strong>2012</strong><br />

Products Affected - Description<br />

Dacarbazine powder for injection, APP<br />

200 mg vial (NDC 63323-0128-20)<br />

Dacarbazine powder for injection, Hospira<br />

100 mg vial (NDC 61703-0327-22)<br />

Dacarbazine powder for injection, Teva<br />

200 mg vial, 1 count (NDC 00703-5075-01)<br />

200 mg vial, 10 count (NDC 00703-5075-03)<br />

Dacarbazine powder for injection, Bedford<br />

200 mg vial (NDC 55390-0090-10)<br />

Reason for the Shortage<br />

• Teva has dacarbazine on back order due to manufacturing delays.<br />

• Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011.<br />

Product will become available in stages as production resumes.<br />

• Bedford Laboratories has multiple products affected by this suspension of manufacturing.<br />

Availability of all products, including those not manufactured at Ben Venue, is updated as<br />

information changes on the Bedford Laboratories website.<br />

• Hospira has dacarbazine on shortage due to manufacturing delays.<br />

• APP has dacarbazine on shortage due to increased demand for the product.<br />

Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=653<br />

Source: www.ashp.org<br />

51

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!